FDA Approved Products
1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
GVOKE VIALDX
glucagon injection, solution
Peak
INTRAVENOUS · SOLUTION
2019
NDA0/100
HARLIKU
nitisinone
Peak
ORAL · TABLET
2017
NDA0/100
HARVONI
ledipasvir and sofosbuvir
Peak
Gilead Sciences
ORAL · PELLETS
2019
SMNDA0/100
HARVONI
ledipasvir and sofosbuvir
Peak
Gilead Sciences
ORAL · TABLET
2014
SMNDA0/100
HEMADY
dexamethasone
Peak
Bridge Therapeutics
ORAL · TABLET
2019
NDA0/100
HETLIOZ
tasimelteon
Peak
Vanda Pharmaceuticals
ORAL · CAPSULE
2014
NDA0/100
HETLIOZ LQ
tasimelteon
Peak
Vanda Pharmaceuticals
ORAL · SUSPENSION
2020
NDA0/100
IBRANCE
palbociclib
Peak
Pfizer
ORAL · CAPSULE
2015
SMNDA0/100
IBRANCE
palbociclib
Peak
Pfizer
ORAL · TABLET
2019
SMNDA0/100
IBSRELA
tenapanor hydrochloride
Peak
Ardelyx
ORAL · TABLET
irritable bowel syndrome with constipation (IBS-C) in adults
2019
NDA0/100
ICLUSIG
ponatinib hydrochloride
Peak
Takeda
ORAL · TABLET
combination with chemotherapy
2012
NDA0/100
IDHIFA
enasidenib mesylate
Peak
Bristol Myers Squibb
ORAL · TABLET
refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation
2017
NDA0/100
IGALMI
dexmedetomidine
Peak
BioXcel Therapeutics
BUCCAL, SUBLINGUAL · FILM
2022
NDA0/100
IHEEZO
chloroprocaine hydrochloride ophthalmic gel
Peak
OPHTHALMIC · GEL
2022
NDA0/100
ILEVRO
nepafenac
Peak
OPHTHALMIC · SUSPENSION/DROPS
2012
NDA0/100
ILLUCCIX
kit for the preparation of gallium ga 68 gozetotide injection
Peak
Telix Pharmaceuticals
INTRAVENOUS · POWDER
prostate cancer
2021
NDA0/100
IMBRUVICA
ibrutinib
Peak
AbbVie
ORAL · TABLET
2018
SMNDA0/100
IMBRUVICA
ibrutinib
Peak
AbbVie
ORAL · SUSPENSION
2022
SMNDA0/100
IMBRUVICA
ibrutinib
Peak
AbbVie
ORAL · CAPSULE
2013
SMNDA0/100
IMCIVREE
setmelanotide
Peak
Rhythm Pharmaceuticals
SUBCUTANEOUS · SOLUTION
2020
PeptideNDA0/100
IMMPHENTIV
phenylephrine hydrochloride
Peak
Hikma
INTRAVENOUS · SOLUTION
2012
NDA0/100
IMPOYZ
clobetasol propionate
Peak
TOPICAL · CREAM
moderate to severe plaque psoriasis in patients 18 years of ageolder+2
2017
NDA0/100
IMVEXXY
estradiol
Peak
VAGINAL · INSERT
2018
NDA0/100
INBRIJA
levodopa
Peak
Merz Therapeutics
INHALATION · POWDER
2018
NDA0/100